# AZD7687 Multiple Ascending Dose Study

> **NCT01119352** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 45 (actual)

## Conditions studied

- Overweight
- Obese

## Interventions

- **DRUG:** AZD7687
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01119352
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119352, "AZD7687 Multiple Ascending Dose Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01119352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*